Get Premium to unlock powerful stock data

Soleus Capital Management, L.P. Buys DICE Therapeutics Inc, United Therapeutics Corp, Flexion Therapeutics Inc, Sells NovoCure, The Beauty Health Co, IVERIC bio Inc

Author's Avatar
insider
Nov 15, 2021
Article's Main Image
Investment company Soleus Capital Management, L.P. (Current Portfolio) buys DICE Therapeutics Inc, United Therapeutics Corp, Flexion Therapeutics Inc, Enanta Pharmaceuticals Inc, Organogenesis Holdings Inc, sells NovoCure, The Beauty Health Co, IVERIC bio Inc, Itamar Medical, NeoGenomics Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Soleus Capital Management, L.P.. As of 2021Q3, Soleus Capital Management, L.P. owns 70 stocks with a total value of $631 million. These are the details of the buys and sells.

For the details of Soleus Capital Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/soleus+capital+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of Soleus Capital Management, L.P.
  1. BioAtla Inc (BCAB) - 2,515,424 shares, 11.74% of the total portfolio. Shares reduced by 9.98%
  2. C4 Therapeutics Inc (CCCC) - 750,633 shares, 5.32% of the total portfolio. Shares reduced by 13.8%
  3. Lantheus Holdings Inc (LNTH) - 1,229,827 shares, 5.01% of the total portfolio. Shares added by 34.60%
  4. DICE Therapeutics Inc (DICE) - 879,903 shares, 4.57% of the total portfolio. New Position
  5. Theratechnologies Inc (THTX) - 7,612,383 shares, 4.53% of the total portfolio. Shares added by 8.31%
New Purchase: DICE Therapeutics Inc (DICE)

Soleus Capital Management, L.P. initiated holding in DICE Therapeutics Inc. The purchase prices were between $31.92 and $37, with an estimated average price of $34.06. The stock is now traded at around $31.710000. The impact to a portfolio due to this purchase was 4.57%. The holding were 879,903 shares as of 2021-09-30.

New Purchase: United Therapeutics Corp (UTHR)

Soleus Capital Management, L.P. initiated holding in United Therapeutics Corp. The purchase prices were between $179.86 and $214.88, with an estimated average price of $196.99. The stock is now traded at around $205.030000. The impact to a portfolio due to this purchase was 2.98%. The holding were 101,800 shares as of 2021-09-30.

New Purchase: Flexion Therapeutics Inc (FLXN)

Soleus Capital Management, L.P. initiated holding in Flexion Therapeutics Inc. The purchase prices were between $4.4 and $8.2, with an estimated average price of $6.26. The stock is now traded at around $9.160000. The impact to a portfolio due to this purchase was 2.02%. The holding were 2,084,050 shares as of 2021-09-30.

New Purchase: Enanta Pharmaceuticals Inc (ENTA)

Soleus Capital Management, L.P. initiated holding in Enanta Pharmaceuticals Inc. The purchase prices were between $41.02 and $58.65, with an estimated average price of $49.48. The stock is now traded at around $89.880000. The impact to a portfolio due to this purchase was 1.64%. The holding were 182,400 shares as of 2021-09-30.

New Purchase: Organogenesis Holdings Inc (ORGO)

Soleus Capital Management, L.P. initiated holding in Organogenesis Holdings Inc. The purchase prices were between $13.71 and $17.18, with an estimated average price of $15.57. The stock is now traded at around $10.800000. The impact to a portfolio due to this purchase was 1.45%. The holding were 639,887 shares as of 2021-09-30.

New Purchase: Nurix Therapeutics Inc (NRIX)

Soleus Capital Management, L.P. initiated holding in Nurix Therapeutics Inc. The purchase prices were between $22.71 and $36.69, with an estimated average price of $30.82. The stock is now traded at around $33.920000. The impact to a portfolio due to this purchase was 1.25%. The holding were 263,900 shares as of 2021-09-30.

Added: Lantheus Holdings Inc (LNTH)

Soleus Capital Management, L.P. added to a holding in Lantheus Holdings Inc by 34.60%. The purchase prices were between $24.23 and $28.59, with an estimated average price of $26.18. The stock is now traded at around $29.790000. The impact to a portfolio due to this purchase was 1.29%. The holding were 1,229,827 shares as of 2021-09-30.

Added: CareDx Inc (CDNA)

Soleus Capital Management, L.P. added to a holding in CareDx Inc by 332.29%. The purchase prices were between $59.15 and $91.99, with an estimated average price of $76.35. The stock is now traded at around $46.990000. The impact to a portfolio due to this purchase was 0.98%. The holding were 126,661 shares as of 2021-09-30.

Added: Surmodics Inc (SRDX)

Soleus Capital Management, L.P. added to a holding in Surmodics Inc by 37.04%. The purchase prices were between $52.8 and $60.32, with an estimated average price of $55.61. The stock is now traded at around $48.880000. The impact to a portfolio due to this purchase was 0.91%. The holding were 381,522 shares as of 2021-09-30.

Added: Sientra Inc (SIEN)

Soleus Capital Management, L.P. added to a holding in Sientra Inc by 63.25%. The purchase prices were between $5.33 and $8.53, with an estimated average price of $6.84. The stock is now traded at around $5.180000. The impact to a portfolio due to this purchase was 0.84%. The holding were 2,386,063 shares as of 2021-09-30.

Added: ESSA Pharma Inc (EPIX)

Soleus Capital Management, L.P. added to a holding in ESSA Pharma Inc by 28.15%. The purchase prices were between $7.76 and $29.37, with an estimated average price of $15.99. The stock is now traded at around $12.990000. The impact to a portfolio due to this purchase was 0.8%. The holding were 2,868,023 shares as of 2021-09-30.

Added: NeuroPace Inc (NPCE)

Soleus Capital Management, L.P. added to a holding in NeuroPace Inc by 20.64%. The purchase prices were between $15.85 and $25.07, with an estimated average price of $21.07. The stock is now traded at around $12.830000. The impact to a portfolio due to this purchase was 0.72%. The holding were 1,670,136 shares as of 2021-09-30.

Sold Out: MiMedx Group Inc (MDXG)

Soleus Capital Management, L.P. sold out a holding in MiMedx Group Inc. The sale prices were between $5.52 and $15.83, with an estimated average price of $11.35.

Sold Out: Revolution Medicines Inc (RVMD)

Soleus Capital Management, L.P. sold out a holding in Revolution Medicines Inc. The sale prices were between $23.95 and $33.41, with an estimated average price of $29.16.

Sold Out: Alpha Teknova Inc (TKNO)

Soleus Capital Management, L.P. sold out a holding in Alpha Teknova Inc. The sale prices were between $17.47 and $27.49, with an estimated average price of $21.39.

Sold Out: Galecto Inc (GLTO)

Soleus Capital Management, L.P. sold out a holding in Galecto Inc. The sale prices were between $3.59 and $5, with an estimated average price of $4.29.

Sold Out: Insulet Corp (PODD)

Soleus Capital Management, L.P. sold out a holding in Insulet Corp. The sale prices were between $260.36 and $307.27, with an estimated average price of $285.43.

Sold Out: DexCom Inc (DXCM)

Soleus Capital Management, L.P. sold out a holding in DexCom Inc. The sale prices were between $426.84 and $572.73, with an estimated average price of $503.9.



Here is the complete portfolio of Soleus Capital Management, L.P.. Also check out:

1. Soleus Capital Management, L.P.'s Undervalued Stocks
2. Soleus Capital Management, L.P.'s Top Growth Companies, and
3. Soleus Capital Management, L.P.'s High Yield stocks
4. Stocks that Soleus Capital Management, L.P. keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus